It can reduce the epithelial-mesenchymal transition of EOC cells by inhibiting the JAK/STAT3, PI3K/Akt and Notch signalling pathways and block tumour-induced angiogenesis [25]. The gene discussed is AKT1; the disease is neoplasm.